|
Volumn 43, Issue 9, 2002, Pages 1763-1768
|
Indirubin and Meisoindigo in the treatment of chronic myelogenous leukemia in China
|
Author keywords
Chronic myelogenous leukemia treatment; Indirubin; Meisoindigo
|
Indexed keywords
BUSULFAN;
HYDROXYUREA;
INDIRUBIN;
MEISOINDIGO;
PLANT MEDICINAL PRODUCT;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTHRALGIA;
ARTICLE;
BLAST CELL CRISIS;
CANCER INCIDENCE;
CANCER SURVIVAL;
CELL PROLIFERATION;
CHINA;
CHINESE MEDICINE;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG STRUCTURE;
EDEMA;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HEART FAILURE;
HUMAN;
LEUKEMIA REMISSION;
MYALGIA;
NAUSEA;
NONHUMAN;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
STOMACH HEMORRHAGE;
SURVIVAL TIME;
TRADITIONAL MEDICINE;
VOMITING;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
BLAST CRISIS;
CHINA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
HYDROXYUREA;
INDOLES;
LEUKEMIA, MYELOID, CHRONIC;
MICE;
MODELS, CHEMICAL;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0036332286
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/1042819021000006295 Document Type: Article |
Times cited : (270)
|
References (34)
|